Voya Investment Management LLC Glycomimetics Inc Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.16 - $3.18 $131,978 - $194,301	-61,101 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.89 - $4.22 $122,223 - $178,472	42,292 Added 224.85%	61,101 $184,000
Q4 2020 Feb 16, 2021	BUY	$2.69 - $4.24 $20,667 - $32,575	7,683 Added 69.05%	18,809 $71,000
Q2 2020 Aug 14, 2020	SELL	$2.06 - $3.76 $15,141 - $27,636	-7,350 Reduced 39.78%	11,126 $42,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $6.5 $14,483 - $23,361	3,594 Added 24.15%	18,476 $98,000
Q4 2018 Feb 14, 2019	BUY	$8.47 - $14.71 $18,617 - $32,332	2,198 Added 17.33%	14,882 $141,000
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.19 $185,566 - $243,405	12,684 New	12,684 $205,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.